AnaptysBio, Inc. (ANAB) Cash Flow Statement
AnaptysBio, Inc. (ANAB) generated $18.1M of operating cash flow over the twelve months to 2026-06-30, spent $0 on capital expenditure and had free cash flow of $18.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ANABAnaptysBio, Inc.Follow ANAB — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -19.4 | -48.5 | -69.5 | -14.2 | -45.9 | -73.6 | -120.8 | -135.3 | 19.7 | 18.1 | |
| Capital expenditure | 0.3 | 1.1 | 0.8 | 0.6 | 1.4 | 0.4 | 0.8 | 0.0 | 0.0 | -0.0 | |
| Free cash flow | -19.7 | -49.6 | -70.3 | -14.7 | -47.3 | -74.0 | -121.6 | -135.3 | 19.7 | 18.1 | |
| Share repurchases | 0.0 | 0.0 | — | — | 0.0 | 0.0 | 50.0 | 0.5 | 68.6 | — | |
| Stock-based compensation | 4.4 | — | — | — | 15.3 | 27.4 | 33.2 | 7.2 | 3.8 | — |
USD millions · SEC XBRL
AnaptysBio, Inc. — questions
- What is AnaptysBio, Inc.'s operating cash flow?
- $18.1M over the twelve months to 2026-06-30.
- How much does AnaptysBio, Inc. spend on capital expenditure?
- $0 over the twelve months to 2026-06-30.
- What is AnaptysBio, Inc.'s free cash flow?
- $18.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from AnaptysBio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.